4  0   <br/><br/>
Guidelines for the programmatic management of drug-resistant tuberculosis :  [emergency update 2008] /      6 
       6     
[Steering Group, Ernesto Jaramillo ... et al.] 
 - Emergency update.   
 -     
 - xxi, 247 p.     24 cm.     
 -   
 -   
 - 
 - 
 -         .
 -     .
 -          0   .
 -         .
 -  0       .
<br/><br/>   WHO/HTM/TB/2008.402. 
<br/><br/>Includes bibliographical references and index. 
<br/><br/>Background information on DR-TB -- Framework for effective control of DR-TB -- Political commitment and coordination -- Definitions : case registration, bacteriology and treatment outcomes -- Case-finding strategies -- Laboratory aspects -- Treatment strategies for MDR-TB and XDR-TB -- Mono-resistant and poly-resistant strains -- Treatment of DR-TB in special conditions and situations -- DR-TB and HIV infection -- Initial evaluation, monitoring of treatment and management of adverse effects -- Treatment delivery and community-based DR-TB support -- Management of patients after MDR-TB treatment failure -- Management of contacts of MDR-TB patients -- Drug resistance and infection control -- Human resources : training and staffing -- Management of second-line antituberulosis drugs -- Category IV recording and reporting system -- Managing DR-TB through patient-centred care.       
<br/><br/>   5 
<br/><br/>      
<br/><br/> The emergence of extensively drug-resistant strains of tuberculosis, especially in countries with a high prevalence of human immunodeficiency virus, is a serious threat to global public health and jeopardizes efforts to effectively control the disease. This publication offers updated recommendations for the diagnosis and management of drug-resistant tuberculosis in a variety of geographical, economic and social settings, and the recording of data that enables the monitoring and evaluation of programs.--Publisher's description.       
<br/><br/>      
<br/><br/>
<br/><br/><br/> <br/> <br/> <br/> <br/> <br/> <br/> 
<br/><br/><br/>5     
<br/><br/><br/> <br/>   
<br/><br/><label>ISBN: </label>9789241547581;9241547588   
<br/><br/><label>ISSN: </label>2 
 =   
 =   
<br/><br/><label>Standard No.: </label>        
<br/><br/><label>Publisher. No.: </label>  
<br/><br/><label>Source: </label>        
<br/><br/><label>LCCN: </label>
<br/><br/><label>Nat. Bib. No.: </label> 2 
<br/><br/><label>Nat. Bib. Agency Control No.: </label>    
<br/><br/><label>Subjects--Personal Names: </label><br/>     2     --0------
<br/><br/><label>Subjects--Corporate Names: </label><br/>     6 --0-- 2 --------
<br/><br/><label>Subjects--Meeting Names: </label><br/><br/> 0    2 --
<br/><br/><label>Subjects--Uniform Titles: </label><br/>  --20------
<br/><br/><label>Subjects--Chronological Terms: </label><br/> 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Multidrug-resistant tuberculosis;Multidrug-resistant tuberculosis;Antitubercular agents.;HIV infections;Comorbidity;Highly active antiretroviral therapy.;Tuberculosis, Multidrug-Restant;Tuberculosis, Multidrug-Restant;Antitubercular Agents;HIV Infections;Antiretroviral Therapy, Highly Active.    ----Chemotherapy.;Prevention.;Chemotherapy.;Treatment.;drug therapy.;prevention & control.;administration & dosage.;drug therapy.----20--
<br/><br/><label>Subjects--Geographic Terms: </label><br/>--------20--
<br/><br/><label>Index Terms--Genre/Form: </label><br/>----2
<br/><br/><label>LC Class. No.: </label>RA644.T7  / G85 20082 
<br/><br/><label>Dewey Class. No.: </label> / 2 
<br/><br/><label>National Agricultural Library Call No.: </label> /  
<br/><br/><label>National Library of Medicine Call No.: </label> /  
<br/><br/><label>Gov. Doc. Class. No.: </label>